Genstar Capital has formed a strategic relationship with Dr. David Dodd and Bud Ingalls, in order to accelerate Genstar's investment efforts in the life sciences sector. Dodd is the former CEO of Serologics Corp., while Ingalls served as Serologics CFO (and, more recently as CardioMEMS CFO). www.gencap.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.